M&A news

BiomEdit Acquires FOLIUM Science in Undisclosed Deal

BiomEdit Acquires FOLIUM Science in Undisclosed Deal

AcquisitionHospitals and Health CareGB

Get the full FOLIUM Science company profile

Access contacts, investors, buying signals & more

Open in Dashboard
FOLIUM Science logo
Acquired

FOLIUM Science

United KingdomHospitals and Health Care

Undisclosed amount

August 30, 2026

BiomEdit, Inc. logo
Acquirer

BiomEdit, Inc.

BiomEdit, Inc. has acquired FOLIUM Science for an undisclosed amount. The deal brings the UK-based bioscience developer under the ownership of the US animal health company, which focuses on microbiome solutions for livestock. FOLIUM Science will operate as part of BiomEdit’s broader portfolio, which is centered on developing novel products for animal health and nutrition.

FOLIUM Science specializes in a patented technology platform called Guided Biotics, which uses naturally occurring mechanisms to selectively remove unwanted pathogenic and spoilage bacteria. Its applications span animal feed, where the technology reduces bacterial burdens in livestock, as well as plant health, targeting pathogens responsible for blight, wilt, and rot. The company also has early-stage work in soil conditioning, aiming to maintain beneficial bacterial colonies for crop productivity.

For BiomEdit, the acquisition expands its technology base beyond its existing microbiome engineering capabilities. FOLIUM’s Guided Biotics are designed to complement other feed additives such as enzymes and probiotics, which aligns with BiomEdit’s focus on integrated solutions for animal production. The deal also gives BiomEdit access to FOLIUM’s work in plant and soil applications, broadening its addressable market beyond animal health into agricultural productivity.

The transaction is expected to combine FOLIUM’s proprietary science with BiomEdit’s development and commercialization infrastructure. BiomEdit has stated that the acquisition will accelerate the path to market for FOLIUM’s products, particularly in the animal feed sector, where bacterial burden management is a key productivity factor. The companies have not disclosed further financial terms or integration timelines.

Post-acquisition, the combined entity will focus on scaling FOLIUM’s technology across both animal and plant applications. The near-term priority will be advancing existing product candidates through regulatory and commercial stages, with the longer-term goal of establishing Guided Biotics as a standard tool in bacterial management across the food and agriculture value chain.

No buying signals identified yet.

Unlock GTM signals

Discover FOLIUM Science's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at FOLIUM Science.

Unlock decision-makers
BiomEdit Acquires FOLIUM Science in Undisclosed Deal | M&A News | Signalbase